Insider · CIK 0001687880
Versant Venture Capital VI, L.P.
Files at LENZ (LENZ Therapeutics, Inc.), GLUE (Monte Rosa Therapeutics, Inc.). First filing Oct 30, 2024, latest Jun 20, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GLUE: Monte Rosa Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | LENZsell LENZ Therapeutics, Inc. | $10M 334,801 shares | -27% | - | |
| 42Moderate | LENZsell LENZ Therapeutics, Inc. | $10M 350,000 shares | -22% | - | |
| 37Weak | GLUEsell Monte Rosa Therapeutics, Inc. | $1.5M 157,895 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | LENZ LENZ Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -100,000 | $29.95 | $3.0M | 1,148,789 | Jun 20, 2025 |
| Jun 20, 2025 | LENZ LENZ Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -100,877 | $30.35 | $3.1M | 1,047,912 | Jun 20, 2025 |
| Jun 20, 2025 | LENZ LENZ Therapeutics, Inc. | SOpen-market sale Common Stock | -133,924 | $30.25 | $4.1M | 1,967,275 | Jun 20, 2025 |
| Jun 10, 2025 | LENZ LENZ Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -350,000 | $29.00 | $10M | 1,248,789 | Jun 12, 2025 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -89,990 | $9.66 | $869k | 2,007,948 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stock | -1,019,867 | $0.00 | $0 | 4,079,469 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stockindirect: See Footnote | +20,397 | $0.00 | $0 | 20,397 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stockindirect: See Footnote | -20,397 | $0.00 | $0 | 0 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stockindirect: See Footnote | +17,595 | $0.00 | $0 | 17,595 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stockindirect: See Footnote | -17,595 | $0.00 | $0 | 0 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stockindirect: See Footnote | -366,590 | $0.00 | $0 | 1,641,358 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stockindirect: See Footnote | +5,499 | $0.00 | $0 | 5,499 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stockindirect: See Footnote | -5,499 | $0.00 | $0 | 0 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stockindirect: See Footnote | +5,454 | $0.00 | $0 | 5,454 | Oct 30, 2024 |
| Oct 28, 2024 | GLUE Monte Rosa Therapeutics, Inc. | JOther Common Stockindirect: See Footnote | -5,454 | $0.00 | $0 | 0 | Oct 30, 2024 |
| Oct 29, 2024 | GLUE Monte Rosa Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -52,305 | $9.08 | $475k | 1,589,053 | Oct 30, 2024 |
| Oct 29, 2024 | GLUE Monte Rosa Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -15,600 | $9.41 | $147k | 1,573,453 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.